This year, Normec has taken an important step in supporting forest conservation efforts in the Copperbelt region of Zambia. We are helping small-scale farmers protect and restore the native miombo forests by planting 10,000 trees, equivalent to offsetting 1,000 tCO2.

Amsterdam, Zoersel, 16 september 2024 - Normec, een toonaangevende leverancier van diensten op het gebied van testen, inspectie, certificering en compliance (TICC), is verheugd om de samenwerking met 2 Bridge aan te kondigen. 2 Bridge is gespecialiseerd in de ontwikkeling van medicijnen en biedt cruciale operationele en strategische ondersteuning aan life sciences bedrijven, waaronder investeerders, bio-techs en TTO's.

Amsterdam, Northampton, 12 September 2024 - Normec, a leader in testing, inspection, certification and compliance (TICC) services, is excited to announce to partner with 20/30 Labs Limited. 20/30 is a leading provider of microbiological testing; with specialisms in medical device testing, medical device research, and water testing services. By partnering with 20/30 Labs Limited, Normec aims to expand its capabilities in the microbiological and environmental testing markets, addressing the growing demand for rigorous testing standards and compliance here and in related industries. This strategic partnership enhances Normec's service portfolio in the UK and strengthens its position as a comprehensive provider of testing solutions.

Amsterdam, Dublin, 12 August 2024 – Normec, a leading provider of Testing, Inspection, Certification, and Compliance (TICC) services, is delighted to announce its acquisition of MIAS Pharma, a distinguished provider of pharmaceutical consulting and Qualified Person (QP) services based in Ireland and the UK.

Amsterdam, Wednesday, July 10 – Normec, a market leader in the TICC sector (Testing, Inspection, Certification, Compliance), has been acquired for an amount exceeding €2 billion. This transaction is financed through a combination of refinancing and a capital injection of €1.4 billion, raised by the pan-European investment fund Astorg. Normec will continue its acquisition strategy in Europe and is also exploring expansion opportunities in the United States.